These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7600744)

  • 1. Is ACE inhibition with lisinopril helpful in diabetic neuropathy?
    Reja A; Tesfaye S; Harris ND; Ward JD
    Diabet Med; 1995 Apr; 12(4):307-9. PubMed ID: 7600744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ranirestat for the management of diabetic sensorimotor polyneuropathy.
    Bril V; Hirose T; Tomioka S; Buchanan R;
    Diabetes Care; 2009 Jul; 32(7):1256-60. PubMed ID: 19366965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid reversal of a motor nerve conduction deficit in streptozotocin-diabetic rats by the angiotensin converting enzyme inhibitor lisinopril.
    Cameron NE; Cotter MA; Robertson S
    Acta Diabetol; 1993; 30(1):46-8. PubMed ID: 8392403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of ranirestat (AS-3201) on peripheral nerve function in patients with diabetic sensorimotor polyneuropathy.
    Bril V; Buchanan RA
    Diabetes Care; 2006 Jan; 29(1):68-72. PubMed ID: 16373898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A meta-analysis of trials on aldose reductase inhibitors in diabetic peripheral neuropathy. The Italian Study Group. The St. Vincent Declaration.
    Nicolucci A; Carinci F; Cavaliere D; Scorpiglione N; Belfiglio M; Labbrozzi D; Mari E; Benedetti MM; Tognoni G; Liberati A
    Diabet Med; 1996 Dec; 13(12):1017-26. PubMed ID: 8973882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomised double-blind controlled trial.
    Malik RA; Williamson S; Abbott C; Carrington AL; Iqbal J; Schady W; Boulton AJ
    Lancet; 1998 Dec 19-26; 352(9145):1978-81. PubMed ID: 9872248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between electroneurographic changes and serum ubiquitin levels in patients with type 2 diabetes.
    Akarsu E; Pirim I; Capoğlu I; Deniz O; Akçay G; Unüvar N
    Diabetes Care; 2001 Jan; 24(1):100-3. PubMed ID: 11194212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral nerve function is increasingly impaired during puberty in adolescents with type 1 diabetes.
    Riihimaa PH; Suominen K; Tolonen U; Jäntti V; Knip M; Tapanainen P
    Diabetes Care; 2001 Jun; 24(6):1087-92. PubMed ID: 11375375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproducibility of parameters for assessment of diabetic neuropathy. The French Group for Research and Study of Diabetic Neuropathy.
    Valensi P; Attali JR; Gagant S
    Diabet Med; 1993 Dec; 10(10):933-9. PubMed ID: 8306589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycemic control is related to the electrophysiologic severity of diabetic peripheral sensorimotor polyneuropathy.
    Tkac I; Bril V
    Diabetes Care; 1998 Oct; 21(10):1749-52. PubMed ID: 9773742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tocotrienol-Rich Vitamin E (Tocovid) Improved Nerve Conduction Velocity in Type 2 Diabetes Mellitus Patients in a Phase II Double-Blind, Randomized Controlled Clinical Trial.
    Chuar PF; Ng YT; Phang SCW; Koay YY; Ho JI; Ho LS; Botross Henien NP; Ahmad B; Abdul Kadir K
    Nutrients; 2021 Oct; 13(11):. PubMed ID: 34836025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subclinical nerve dysfunction in children and adolescents with IDDM.
    Hyllienmark L; Brismar T; Ludvigsson J
    Diabetologia; 1995 Jun; 38(6):685-92. PubMed ID: 7672490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between sural nerve morphometric findings and measures of peripheral nerve function in mild diabetic neuropathy.
    Veves A; Malik RA; Lye RH; Masson EA; Sharma AK; Schady W; Boulton AJ
    Diabet Med; 1991 Dec; 8(10):917-21. PubMed ID: 1838042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topiramate and physiologic measures of nerve function in polyneuropathy.
    Freeman R; McIntosh KA; Vijapurkar U; Thienel U
    Acta Neurol Scand; 2007 Apr; 115(4):222-31. PubMed ID: 17376119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated von Willebrand factor antigen predicts deterioration in diabetic peripheral nerve function.
    Plater ME; Ford I; Dent MT; Preston FE; Ward JD
    Diabetologia; 1996 Mar; 39(3):336-43. PubMed ID: 8721780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of gamma-linolenic acid on human diabetic peripheral neuropathy: a double-blind placebo-controlled trial.
    Jamal GA; Carmichael H
    Diabet Med; 1990 May; 7(4):319-23. PubMed ID: 2159860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of near-normoglycaemia for 4 years on somatic nerve dysfunction and heart rate variation in type 1 diabetic patients.
    Ziegler D; Dannehl K; Wiefels K; Gries FA
    Diabet Med; 1992; 9(7):622-9. PubMed ID: 1511568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The electrophysiological findings of subclinical neuropathy in patients with recently diagnosed type 1 diabetes mellitus.
    Karsidag S; Morali S; Sargin M; Salman S; Karsidag K; Us O
    Diabetes Res Clin Pract; 2005 Mar; 67(3):211-9. PubMed ID: 15713353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulse pressure is independently associated with sensorimotor peripheral neuropathy in patients with type 2 diabetes.
    Jarmuzewska EA; Mangoni AA
    J Intern Med; 2005 Jul; 258(1):38-44. PubMed ID: 15953131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of lisinopril on diabetic peripheral neuropathy: experiment with rats].
    Han LP; Yu DM; Xie Y
    Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(35):2513-5. PubMed ID: 19080636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.